Procter & Gamble Health Limited (NSE:PGHL)
India
· Delayed Price · Currency is INR 5,560.50
-18.50 (-0.33%)
Jun 6, 2025, 3:29 PM IST
Procter & Gamble Health Revenue
Procter & Gamble Health had revenue of 3.11B INR in the quarter ending March 31, 2025, with 23.17% growth. This brings the company's revenue in the last twelve months to 12.18B, up 4.24% year-over-year. In the fiscal year ending June 30, 2024, Procter & Gamble Health had annual revenue of 11.51B, down -6.37%.
Revenue (ttm)
12.18B
Revenue Growth
+4.24%
P/S Ratio
7.56
Revenue / Employee
9.12M
Employees
1,336
Market Cap
92.13B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 11.51B | -783.60M | -6.37% |
| Jun 30, 2023 | 12.30B | 1.15B | 10.34% |
| Jun 30, 2022 | 11.14B | 1.06B | 10.48% |
| Jun 30, 2021 | 10.09B | 1.20B | 13.52% |
| Jun 30, 2020 | 8.89B | -380.06M | -4.10% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 525.78B |
| Divi's Laboratories | 93.60B |
| Cipla | 271.45B |
| Apollo Hospitals Enterprise | 217.94B |
| Mankind Pharma | 122.07B |
| Zydus Lifesciences | 232.42B |
| Aurobindo Pharma | 317.24B |
| Alkem Laboratories | 129.65B |
Procter & Gamble Health News
- 7 months ago - P&G Health Q2 FY25: Revenue rises 2.8% YoY to Rs 313.41 crore, net profit surges 25.6% to Rs 82.33 crore - Business Upturn
- 7 months ago - Procter & Gamble Health Q2 FY25 results: Stock jumps 2% ahead of result announcement - Business Upturn